A detailed history of Ntv Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Ntv Asset Management LLC holds 10,889 shares of AMGN stock, worth $3.05 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
10,889
Previous 11,039 1.36%
Holding current value
$3.05 Million
Previous $3.45 Million 1.71%
% of portfolio
0.48%
Previous 0.5%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$309.38 - $337.38 $46,407 - $50,607
-150 Reduced 1.36%
10,889 $3.51 Million
Q2 2024

Jul 31, 2024

BUY
$262.75 - $319.31 $20,494 - $24,906
78 Added 0.71%
11,039 $3.45 Million
Q1 2024

May 07, 2024

BUY
$268.87 - $324.56 $9,141 - $11,035
34 Added 0.31%
10,961 $3.12 Million
Q4 2023

Feb 06, 2024

SELL
$255.7 - $288.46 $19,688 - $22,211
-77 Reduced 0.7%
10,927 $3.15 Million
Q3 2023

Nov 06, 2023

BUY
$218.65 - $271.46 $32,797 - $40,719
150 Added 1.38%
11,004 $2.96 Million
Q2 2023

Aug 02, 2023

BUY
$214.27 - $253.37 $21,427 - $25,337
100 Added 0.93%
10,854 $2.41 Million
Q1 2022

May 06, 2022

SELL
$219.27 - $242.57 $15,348 - $16,979
-70 Reduced 0.65%
10,754 $2.6 Million
Q4 2021

Feb 04, 2022

SELL
$198.88 - $227.6 $49,720 - $56,900
-250 Reduced 2.26%
10,824 $2.44 Million
Q3 2021

Nov 10, 2021

SELL
$212.27 - $248.7 $153,895 - $180,307
-725 Reduced 6.14%
11,074 $2.36 Million
Q2 2021

Aug 09, 2021

SELL
$233.58 - $259.14 $71,241 - $79,037
-305 Reduced 2.52%
11,799 $2.88 Million
Q1 2021

May 10, 2021

SELL
$221.91 - $258.6 $33,286 - $38,790
-150 Reduced 1.22%
12,104 $3.01 Million
Q4 2020

Feb 05, 2021

SELL
$216.38 - $257.67 $10,819 - $12,883
-50 Reduced 0.41%
12,254 $2.82 Million
Q2 2020

Aug 07, 2020

BUY
$197.81 - $242.74 $54,397 - $66,753
275 Added 2.29%
12,304 $2.9 Million
Q1 2020

May 06, 2020

SELL
$182.24 - $241.7 $18,224 - $24,170
-100 Reduced 0.82%
12,029 $2.44 Million
Q4 2019

Jan 30, 2020

SELL
$189.21 - $243.2 $37,842 - $48,640
-200 Reduced 1.62%
12,129 $2.92 Million
Q3 2019

Nov 04, 2019

BUY
$174.11 - $208.62 $1,741 - $2,086
10 Added 0.08%
12,329 $2.39 Million
Q2 2019

Jul 29, 2019

SELL
$166.7 - $195.41 $51,510 - $60,381
-309 Reduced 2.45%
12,319 $2.27 Million
Q1 2019

Apr 29, 2019

SELL
$180.87 - $203.88 $18,087 - $20,388
-100 Reduced 0.79%
12,628 $2.4 Million
Q4 2018

Jan 28, 2019

SELL
$178.4 - $208.25 $44,600 - $52,062
-250 Reduced 1.93%
12,728 $2.48 Million
Q3 2018

Nov 08, 2018

SELL
$185.29 - $208.89 $23,161 - $26,111
-125 Reduced 0.95%
12,978 $2.69 Million
Q2 2018

Aug 06, 2018

SELL
$166.05 - $186.51 $4,151 - $4,662
-25 Reduced 0.19%
13,103 $2.42 Million
Q3 2017

Nov 06, 2017

BUY
$167.29 - $191.0 $317,851 - $362,900
1,900 Added 16.92%
13,128 $2.45 Million
Q2 2017

Aug 08, 2017

BUY
N/A
11,228
11,228 $1.93 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ntv Asset Management LLC Portfolio

Follow Ntv Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ntv Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ntv Asset Management LLC with notifications on news.